ConAlliance serves M&A advice to medical products companies in all major geographies, including medical supplies, capital equipment, implantable devices, and others.
In developed markets, our experience working with leading payors, providers, and regulators allows us to provide a unique advice when selling or buying a medical device company.

ConAlliance provides strategic advice on a full range of medical device transactions, including:

• Company sales and divestitures
• Acquisitions
• Management buy-outs or buy-ins
• Leveraged buyouts
• Mergers
• Privatizations
• Strategic alliances
• Joint ventures

M&A medical product company

 

The most important medical device manufacturers worldwide are (among others): Johnson and Johnson , Medtronic , GE Healthcare , Cardinal Health , Baxter International, Tyco Healthcare, Kodak Health Group , Hospira , Smith & Nephew , Boston Scientific , Stryker , B. Braun , St. Jude Medical , Guidant Corp., Siemens Medical Solutions , Philips Medical Systems , Fresenius , 3M Healthcare , Zimmer Holdings , Becton, Dickinson & Co. , Synthes , Alcon , Biomet , C. R. Bard , Terumo , Dentsply International , Invacare , Gambro , Dräger Medical , Varian Medical ,

M&A Advisor

the authorization of medical products for human use as well as the supervision of pharmaceutical companies are shared by different German authorities on the national and federal state level.

In M&A it is important is important to distinguish, i.e. medicinal products, medical products, medical devices, food products or cosmetics. The difference, for example, between medicinal products and medical devices is of great importance for the manufacturer, because medicinal products only can be marketed after a marketing authorization has been granted. Medical devices, for example, must undergo only a conformity-assessment procedure which is faster and less costly than medicinal product authorization.

Mergers and Acquisitions

ConAlliance Investmentbanking advises in acquiring medical product companies in Europe.

The reimbursability of the target’s products has a very significant financial impact on the deal.

M&A consulting

M&A advisory services

m&a healthcare

ConAlliance healthcare investment banking and M&A services reach from medical technology, healthcare services, information-driven healthcare technology, life science tools and diagnostics to biopharmaceuticals and medical devices and pharmaceutical companies.

acquire medical device business

Our clients cover a broad spectrum of sectors including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies and devices.

mergers & acquisitions healthcare

ConAlliance is an German investment banking firm that focuses exclusively on the health care industry. Our clients include medical technology companies, pharmaceutical and biotech companies, health care information technology, private equity and venture capital. ConAlliance has one of the most experienced healthcare M&A teams in Germany with subsidiaries and offices in the USA and China and the most important countries in Europe. Operating out of offices in Germany, ConAlliance provides mergers & acquisitions, strategic and financial advisory solutions for its healthcare clients.

mergers and acquisitions life science

Within the life sciende industry our services comprise mergers and acquisitions, private placements, valuations and fairness opinions, distressed M&A, ....

ConAlliance is the leading European M&A advisory firm with respect to mergers acquisitions of medical devices.

m&a medical products mergers & acquisitions investmentbanking

sell medical device company

 

medical devices include heart implants and orthopedic implants, but that only begins to scratch the surface. Surgical equipment, radiological equipment, stretchers, wheelchairs, and hospital beds all fall under the medical device category. Basically, if you go into a hospital, anything that "do[es] not achieve its intended use through chemical reaction and [is] not metabolized in the body" is considered devices.

healthcare investment banking

Mergers and acquisitions is a perfect tool for healthcare companies to stimulate inorganic growth – that means growth through licences, acquisitions and partnerships.

mergers & acquisitions wound care m&a

ConAlliance has a significant track record in completed transactions within the wound care sector. Our M&A advisors do not only know about investment banking, but also have deep insights into the wound care business. Wound care companies develop a full line of products to actively promote wound healing, maintain moist wound healing environment and control bacteria.

ConAlliance major wound care deals

• wound care deals by Type: table showing information including the number of deals and value such as Mergers and Acquisitions, Equity/Debt Offering etc.
• wound care deals by region - table depicting information on the number of deals and value including North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
• wound care deals by Sub-sector - table presenting information on the number of deals and value reported by the company, by sub-sector.
  

We are a longstanding leader in advising healthcare M&A transactions with special emphasis on medical devices.